Izotropic Stock Performance
| IZOZF Stock | USD 0.17 0.02 10.53% |
The company retains a Market Volatility (i.e., Beta) of -1.72, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Izotropic are expected to decrease by larger amounts. On the other hand, during market turmoil, Izotropic is expected to outperform it. Izotropic right now retains a risk of 9.73%. Please check out Izotropic maximum drawdown and the relationship between the expected short fall and period momentum indicator , to decide if Izotropic will be following its current trending patterns.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Izotropic has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Izotropic is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 4.1 M | |
| Total Cashflows From Investing Activities | -24.2 K |
Izotropic |
Izotropic Relative Risk vs. Return Landscape
If you would invest 22.00 in Izotropic on April 21, 2025 and sell it today you would lose (5.00) from holding Izotropic or give up 22.73% of portfolio value over 90 days. Izotropic is currently producing 0.061% returns and takes up 9.7321% volatility of returns over 90 trading days. Put another way, 87% of traded otc stocks are less volatile than Izotropic, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Izotropic Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Izotropic's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Izotropic, and traders can use it to determine the average amount a Izotropic's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0063
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | IZOZF |
| Negative Returns |
Estimated Market Risk
| 9.73 actual daily | 87 87% of assets are less volatile |
Expected Return
| 0.06 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Izotropic is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Izotropic by adding Izotropic to a well-diversified portfolio.
Izotropic Fundamentals Growth
Izotropic OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Izotropic, and Izotropic fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Izotropic OTC Stock performance.
| Return On Equity | -374.4 | |||
| Return On Asset | -1.6 | |||
| Current Valuation | 26.87 M | |||
| Shares Outstanding | 51.85 M | |||
| Price To Book | 115.81 X | |||
| EBITDA | (6.63 M) | |||
| Cash And Equivalents | 1.43 M | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 2.03 M | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | (4.76 M) | |||
| Earnings Per Share | (0.12) X | |||
| Total Asset | 2.27 M | |||
About Izotropic Performance
By analyzing Izotropic's fundamental ratios, stakeholders can gain valuable insights into Izotropic's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Izotropic has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Izotropic has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Izotropic Corporation, a MedTech company, commercializes diagnostic products for breast cancer. The company was incorporated in 2016 and is headquartered in Surrey, Canada. Izotropic Corp operates under Diagnostics Research classification in the United States and is traded on OTC Exchange.Things to note about Izotropic performance evaluation
Checking the ongoing alerts about Izotropic for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Izotropic help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Izotropic had very high historical volatility over the last 90 days | |
| Izotropic has some characteristics of a very speculative penny stock | |
| Izotropic has high likelihood to experience some financial distress in the next 2 years | |
| Izotropic has accumulated 2.03 M in total debt. Izotropic has a current ratio of 0.74, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Izotropic until it has trouble settling it off, either with new capital or with free cash flow. So, Izotropic's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Izotropic sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Izotropic to invest in growth at high rates of return. When we think about Izotropic's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (6.65 M) with loss before overhead, payroll, taxes, and interest of (52.5 K). | |
| Izotropic has accumulated about 1.43 M in cash with (4.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03. |
- Analyzing Izotropic's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Izotropic's stock is overvalued or undervalued compared to its peers.
- Examining Izotropic's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Izotropic's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Izotropic's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Izotropic's otc stock. These opinions can provide insight into Izotropic's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Izotropic OTC Stock analysis
When running Izotropic's price analysis, check to measure Izotropic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Izotropic is operating at the current time. Most of Izotropic's value examination focuses on studying past and present price action to predict the probability of Izotropic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Izotropic's price. Additionally, you may evaluate how the addition of Izotropic to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |